Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 10, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
- Shares Purchased: 508,000 ordinary shares
- Highest Price Paid: 395.70 pence per share
- Lowest Price Paid: 391.50 pence per share
- Volume Weighted Average Price: 394.1235 pence per share
- Post-Transaction Share Capital: 9,120,870,772 ordinary shares
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of the 508,000 repurchased shares. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed transaction. The filing notes that a full breakdown of individual trades is available via the London Stock Exchange and the company's investor website.
Investor Verification Checklist
- Verify the total number of shares repurchased to date under the August 2024 Buyback Programme.
- Confirm the remaining authorized buyback amount and the programme's end date.
- Review the full trade breakdown at the provided RNS link for intraday pricing details.
- Check the updated share capital figure against the company's latest annual report to confirm the reduction.